19th Apr 2007 10:01
ReGen Therapeutics PLC19 April 2007 19 April 2007 ReGen Therapeutics Plc HOLDINGS IN COMPANY ReGen Therapeutics Plc (the 'Company') announces that it had receivednotification by the 20 March pursuant to the transitional provisions of theDisclosure and Transparency Rules that the following directors and majorshareholders are interested in 3% or more of the voting rights of the Company'sissued share capital. % of total Voting rights voting rights Directors Peter Garrod 71,750,000 8.48% Other major shareholders Barclays PLC on behalf of 45,006,393 5.32%Barclays Stockbrokers LtdGerrard Ltd Tigran Kalaydjian 26,250,000 3.10% The above percentages are based on 846,146,110 ordinary shares being the totalnumber of the Company's issued ordinary shares each carrying voting rights. For further information, please contact: Andrew Marshall Tel. 020 7960 6007Greycoat Communications This information is provided by RNS The company news service from the London Stock ExchangeRelated Shares:
TILS.LBarclays